IRS Publishes Latest List of Americans Who Renounced Citizenship
Published Date: 7/23/2026
Notice
Summary
Every few months, the IRS shares a list of people who gave up their U.S. citizenship or long-term resident status. This update covers those who lost it by June 30, 2026. If you’re thinking about expatriating, know this process is official, public, and can have tax and timing consequences.
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-18219, Car Loan Interest Deduction
This document contains final regulations regarding the deduction for certain taxpayers for an amount up to $10,000 of qualified passenger vehicle loan interest. This document also contains final regulations regarding new information reporting requirements for certain persons who, in a trade or business, receive from any individual interest aggregating $600 or more for any calendar year on a specified passenger vehicle loan, including applicable penalties for failures to file information returns or furnish payee statements as required. These regulations affect taxpayers that may deduct qualified passenger vehicle loan interest, and also persons subject to these information reporting requirements.
2026-17622, Federal Independent Dispute Resolution Operations; Correction
This document corrects typographical errors and omissions in the final rule that appeared in the June 4, 2026, Federal Register titled "Federal Independent Dispute Resolution Operations" (referred to hereafter as the "IDR final rule"). The effective date of the IDR final rule was August 3, 2026.
2026-11343, Trump Accounts; Hearing
The IRS is holding a public hearing on July 16, 2026, about new rules for opening Trump accounts. People interested in speaking must submit their topics by June 15, or the hearing gets canceled. These changes could affect how certain accounts are managed and reported, so stay tuned for updates that might impact your money and taxes.
2026-11140, Federal Independent Dispute Resolution Operations
Starting soon, health plans and insurers must share clearer info when they pay or deny surprise medical bills. They’ll use special codes to explain these decisions, especially when dealing with folks they don’t have contracts with. This helps patients and providers understand bills better and speeds up fixing disputes, with no extra costs for most people.
2026-09141, Section 45Z Clean Fuel Production Credit; Hearing
The IRS is holding a telephonic-only public hearing from May 27-29, 2026, about new rules for clean fuel production credits. These rules explain who can get credits, how to measure emissions, and how to register. If you’re involved in clean fuel, this could affect your money and how you apply for credits.
2026-08344, Section 45Z Clean Fuel Production Credit; Hearing
The IRS is holding a public hearing in late May 2026 to talk about new rules for the Clean Fuel Production Credit. These rules will explain who can get the credit, how to measure emissions, and what paperwork is needed. If you make clean fuel, these changes could affect your tax credits and when you can claim them.
Previous / Next Documents
Previous: 2026-14838, Agency Information Collection Activities; Proposed eCollection, eComments Requested; Revision of a Previously Approved Collection; Title-Recordkeeping for Partial fills of Prescriptions
The DEA is updating how pharmacies and drug handlers keep records when prescriptions are only partly filled. This affects anyone who manages controlled substances and aims to make recordkeeping clearer and easier, with a chance to comment until September 21, 2026. The update won’t cost extra but will help keep drug tracking accurate and smooth.
Next: 2026-14848, Prospective Grant of an Exclusive Patent License: RXFP1 AGONISTS
The National Institutes of Health plans to give Modala Bio an exclusive license to use new RXFP1 agonist inventions that could help treat diseases like cancer, heart failure, and fibrosis. This means Modala Bio gets special rights to develop and sell these promising medicines worldwide. If you want to comment or apply for a license, you have until August 24, 2026, so don’t miss out!